The Specialized Programs of Research Excellence (SPOREs) in Human Cancers grant supports research excellence in human cancers for the years 2027 through 2029. This opportunity requires a P50 clinical trial and is provided by the National Institutes of Health. Specific eligibility and detailed description are not provided in the listing.
Eligibility details are not specified in the grant listing. Contact the funding organization for requirements.
